Exact Sciences buys biotech to advance multi-cancer test goal
Cancer diagnostics company Exact Sciences Corp. has purchased OmicEra Diagnostics, a German startup specializing in proteomics, or large-scale protein analysis.
The deal closed Monday, according to a filing with the U.S. Securities and Exchange Commission.
